Although exogeneous insulin is generally used for T1DM treatment, it is difficult to prevent the long-term side effects of insulin that arise from the inability to precisely respond to the blood glucose concentration [1,2,3]. This evidence concerns the gene INS and type 1 diabetes mellitus.